Zantac and other ranitidine products were withdrawn nationwide in April 2020 over concerns an impurity could cause cancer.

FDA clears reformulated ranitidine after five years, ensuring safety with new labeling and storage instructions for acid-reducing treatment.

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) is requesting that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market. The ...